209 related articles for article (PubMed ID: 20157019)
1. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma.
Asgari MM; Chren MM; Warton EM; Friedman GD; White E
Arch Dermatol; 2010 Apr; 146(4):388-95. PubMed ID: 20157019
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
[TBL] [Abstract][Full Text] [Related]
3. Association of tea consumption and cutaneous squamous cell carcinoma.
Asgari MM; White E; Warton EM; Hararah MK; Friedman GD; Chren MM
Nutr Cancer; 2011; 63(2):314-8. PubMed ID: 21240832
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Reinau D; Surber C; Jick SS; Meier CR
Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
Johannesdottir SA; Chang ET; Mehnert F; Schmidt M; Olesen AB; Sørensen HT
Cancer; 2012 Oct; 118(19):4768-76. PubMed ID: 22644960
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin.
Butler GJ; Neale R; Green AC; Pandeya N; Whiteman DC
J Am Acad Dermatol; 2005 Dec; 53(6):966-72. PubMed ID: 16310056
[TBL] [Abstract][Full Text] [Related]
7. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study.
Torti DC; Christensen BC; Storm CA; Fortuny J; Perry AE; Zens MS; Stukel T; Spencer SK; Nelson HH; Karagas MR
J Am Acad Dermatol; 2011 Aug; 65(2):304-312. PubMed ID: 21529996
[TBL] [Abstract][Full Text] [Related]
8. Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma.
Asgari MM; Warton EM; Whittemore AS
Dermatol Surg; 2015 Apr; 41(4):481-6. PubMed ID: 25760557
[TBL] [Abstract][Full Text] [Related]
9. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.
Asgari MM; Maruti SS; White E
J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752
[TBL] [Abstract][Full Text] [Related]
10. Supplement use and risk of cutaneous squamous cell carcinoma.
Asgari MM; Chren MM; Warton EM; Friedman GD; White E
J Am Acad Dermatol; 2011 Dec; 65(6):1145-51. PubMed ID: 21664718
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Sørensen HT; Hallas J; Larsen SB; Tjønneland A; Friis S
Cancer Causes Control; 2016 Sep; 27(9):1067-79. PubMed ID: 27503490
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.
Khalaf N; Nguyen T; Ramsey D; El-Serag HB
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1832-9.e6. PubMed ID: 24793026
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
Liao LM; Vaughan TL; Corley DA; Cook MB; Casson AG; Kamangar F; Abnet CC; Risch HA; Giffen C; Freedman ND; Chow WH; Sadeghi S; Pandeya N; Whiteman DC; Murray LJ; Bernstein L; Gammon MD; Wu AH
Gastroenterology; 2012 Mar; 142(3):442-452.e5; quiz e22-3. PubMed ID: 22108196
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Muranushi C; Olsen CM; Pandeya N; Green AC
J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
16. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
18. Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia.
Kleinstern G; Rishi A; Achenbach SJ; Rabe KG; Kay NE; Shanafelt TD; Ding W; Leis JF; Norman AD; Call TG; Cerhan JR; Parikh SA; Baum CL; Slager SL
J Am Acad Dermatol; 2020 Dec; 83(6):1581-1589. PubMed ID: 32682027
[TBL] [Abstract][Full Text] [Related]
19. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.
Grau MV; Baron JA; Langholz B; Karagas M; Greenberg ER; Stukel TA; Mandel JS
Int J Cancer; 2006 Aug; 119(3):682-6. PubMed ID: 16496410
[TBL] [Abstract][Full Text] [Related]
20. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]